Active Therapy with Passive Immunotherapy May Be Effective in the Fight against COVID‐19
نویسندگان
چکیده
منابع مشابه
Genetically modified mosquitos may be used in fight against Zika.
The World Health Organization is considering introducing transgenic mosquitos as a way of tackling the Zika virus. WHO’s vector control advisory group is to be convened in the next few weeks to look at how to control the Aedes Aegypti mosquito, the main vector of the Zika virus. Besides looking at conventional vector control techniques, the group will consider the introduction of transgenic mos...
متن کاملPseudomonas aeruginosa keratitis: passive immunotherapy with antibodies raised against divalent flagellin
Objective(s): Pseudomonas aeruginosa infections such as keratitis are considered among the major health problems worldwide due to the complexity of pathogenesis and antibiotic resistance crisis, thus, finding new effective approaches for prevention and treatment of the infections seem to be still vital. In this report, we aimed to investigate the therapeutic effects of topical administration of...
متن کاملSpecificity may be overrated in cancer immunotherapy
For a long time, cancer immunotherapy has focused on the induction of tumor-specific T cell-mediated immune responses. Now, a mounting body of evidence indicates that efficient anticancer immune responses also rely on innate immunity. Tietze et al. have recently elucidated an antigen-nonspecific role for memory CD8(+) T cells in cytokine-based cancer immunotherapy.
متن کاملCombined active and passive immunization enhances the efficacy of immunotherapy against nicotine in rats.
Vaccination against nicotine reduces the behavioral effects of nicotine in rats, and it is under clinical evaluation as a treatment for tobacco addiction. Efficacy is limited by the need for high serum nicotine-specific antibody (NicAb) levels, and currently available nicotine vaccines do not uniformly generate the required NicAb levels. Passive immunization with a nicotine-specific monoclonal ...
متن کاملActive and passive immunotherapy for neurodegenerative disorders.
Immunotherapeutic strategies to combat neurodegenerative disorders have galvanized the scientific community since the first dramatic successes in mouse models recreating aspects of Alzheimer disease (AD) were reported. However, initial human trials of active amyloid-beta (Abeta) vaccination were halted early because of a serious safety issue: meningoencephalitis in 6% of subjects. Nonetheless, ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical and Translational Science
سال: 2020
ISSN: 1752-8054,1752-8062
DOI: 10.1111/cts.12816